KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis

As an inhibitor of heat shock proteins (HSPs), KNK437 has been reported to play an anti-tumor role in several cancers. But its therapeutic effect and mechanisms in colorectal cancer (CRC) remain unclear. Here, KNK437 sharply inhibited the level of DnaJ heat shock protein family (Hsp40) member A1 (DN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2020-01, Vol.39 (2), p.249-261
Hauptverfasser: Yang, Shaoshan, Ren, Xiaoli, Liang, Yunshi, Yan, Yongrong, Zhou, Yangshu, Hu, Jinlong, Wang, Zhizhi, Song, Fuyao, Wang, Feifei, Liao, Wangjun, Liao, Wenting, Ding, Yanqing, Liang, Li
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 261
container_issue 2
container_start_page 249
container_title Oncogene
container_volume 39
creator Yang, Shaoshan
Ren, Xiaoli
Liang, Yunshi
Yan, Yongrong
Zhou, Yangshu
Hu, Jinlong
Wang, Zhizhi
Song, Fuyao
Wang, Feifei
Liao, Wangjun
Liao, Wenting
Ding, Yanqing
Liang, Li
description As an inhibitor of heat shock proteins (HSPs), KNK437 has been reported to play an anti-tumor role in several cancers. But its therapeutic effect and mechanisms in colorectal cancer (CRC) remain unclear. Here, KNK437 sharply inhibited the level of DnaJ heat shock protein family (Hsp40) member A1 (DNAJA1), followed by DNAJB1, but had little effect on the levels of HSP27, HSP105, HSP90, and HSP70 in CRC cells. DNAJA1 promoted CRC cell proliferation in vitro and tumor growth and metastasis in vivo. Mechanistically, DNAJA1 was activated by E2F transcription factor 1 (E2F1) and then promoted cell cycle by stabilizing cell division cycle protein 45 (CDC45), which could be reversed by KNK437. DNAJA1 was significantly upregulated in CRC tissues and positively correlated with serosa invasion, lymph node metastasis. High level of DNAJA1 predicted poor prognosis for CRC patients. Its expression was highly linked with E2F1 and CDC45 in CRC tissues. More importantly, KNK437 significantly suppressed the growth of DNAJA1 expressing tumor in vivo. The combined treatment of KNK437 with 5-FU/L-OHP chemotherapy reduced liver metastasis of CRC. These data reveal a novel mechanism of KNK437 in anti-tumor therapy of CRC and provides a newly therapeutic strategy with potential translation to the CRC patients.
doi_str_mv 10.1038/s41388-019-0978-0
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2342388211</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A610864906</galeid><sourcerecordid>A610864906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-b3e5ec337c104d22cad5770fa9883037279861b358d1ab2cace4a9c0a4af88703</originalsourceid><addsrcrecordid>eNp1kV1vVCEQhonR2LX6A7wxJF6fdvg6wOVm62ebeqPXZJbDOaXZc6jA-vHvZbPVxkQDCRPmeYcZXkJeMjhjIMx5kUwY0wGzHVjdgkdkxaTuO6WsfExWYBV0lgt-Qp6VcgsA2gJ_Sk5Eo7QRdkXc5fWlFJrmUGqOvhZabwKdcvpebyguA51DxdJ2LDSN1KddysFX3FGPiw-ZfotIK-Yp1LhM9OJ6_XHNzjcXG6ko_ojlOXky4q6EF_fnKfny9s3nzfvu6tO7D5v1VecVqNptRVDBC6E9Azlw7nFQWsOI1hgBQnNtTc-2QpmB4balfZBoPaDE0RgN4pS8Pta9y-nrvg3jbtM-L-1Jx4Xk7Zs4Yw_UhLvg4jKmmtHPsXi37hmYXlroG3X2D6qtIczRpyWMsd3_JWBHgc-plBxGd5fjjPmnY-AOTrmjU6455Q5OuUPDr-4b3m_nMPxR_LamAfwIlJZappAfJvp_1V_v9pql</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2342388211</pqid></control><display><type>article</type><title>KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Yang, Shaoshan ; Ren, Xiaoli ; Liang, Yunshi ; Yan, Yongrong ; Zhou, Yangshu ; Hu, Jinlong ; Wang, Zhizhi ; Song, Fuyao ; Wang, Feifei ; Liao, Wangjun ; Liao, Wenting ; Ding, Yanqing ; Liang, Li</creator><creatorcontrib>Yang, Shaoshan ; Ren, Xiaoli ; Liang, Yunshi ; Yan, Yongrong ; Zhou, Yangshu ; Hu, Jinlong ; Wang, Zhizhi ; Song, Fuyao ; Wang, Feifei ; Liao, Wangjun ; Liao, Wenting ; Ding, Yanqing ; Liang, Li</creatorcontrib><description>As an inhibitor of heat shock proteins (HSPs), KNK437 has been reported to play an anti-tumor role in several cancers. But its therapeutic effect and mechanisms in colorectal cancer (CRC) remain unclear. Here, KNK437 sharply inhibited the level of DnaJ heat shock protein family (Hsp40) member A1 (DNAJA1), followed by DNAJB1, but had little effect on the levels of HSP27, HSP105, HSP90, and HSP70 in CRC cells. DNAJA1 promoted CRC cell proliferation in vitro and tumor growth and metastasis in vivo. Mechanistically, DNAJA1 was activated by E2F transcription factor 1 (E2F1) and then promoted cell cycle by stabilizing cell division cycle protein 45 (CDC45), which could be reversed by KNK437. DNAJA1 was significantly upregulated in CRC tissues and positively correlated with serosa invasion, lymph node metastasis. High level of DNAJA1 predicted poor prognosis for CRC patients. Its expression was highly linked with E2F1 and CDC45 in CRC tissues. More importantly, KNK437 significantly suppressed the growth of DNAJA1 expressing tumor in vivo. The combined treatment of KNK437 with 5-FU/L-OHP chemotherapy reduced liver metastasis of CRC. These data reveal a novel mechanism of KNK437 in anti-tumor therapy of CRC and provides a newly therapeutic strategy with potential translation to the CRC patients.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/s41388-019-0978-0</identifier><identifier>PMID: 31477839</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/109 ; 13/2 ; 13/51 ; 38/44 ; 38/77 ; 38/89 ; 631/67/1059/602 ; 631/67/1504/1885 ; 64/60 ; 82/80 ; Animals ; Apoptosis ; Benzhydryl Compounds - pharmacology ; Cdc45 protein ; Cell Biology ; Cell cycle ; Cell Cycle Proteins - genetics ; Cell division ; Cell proliferation ; Cell Proliferation - drug effects ; Chemotherapy ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - drug therapy ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - pathology ; Cycle protein ; E2F1 protein ; E2F1 Transcription Factor - genetics ; Female ; Gene Expression Regulation, Neoplastic - drug effects ; Growth ; Health aspects ; Heat shock proteins ; Heat-Shock Proteins - antagonists &amp; inhibitors ; Hsp27 protein ; HSP40 Heat-Shock Proteins - genetics ; Hsp40 protein ; Hsp70 protein ; Hsp90 protein ; Human Genetics ; Humans ; Internal Medicine ; Lymph nodes ; Male ; Medical research ; Medicine ; Medicine &amp; Public Health ; Medicine, Experimental ; Metastases ; Metastasis ; Mice ; Neoplasm Metastasis ; Oncology ; Proteins ; Pyrrolidinones - pharmacology ; Signal Transduction - drug effects ; Xenograft Model Antitumor Assays</subject><ispartof>Oncogene, 2020-01, Vol.39 (2), p.249-261</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2019</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>2019© The Author(s), under exclusive licence to Springer Nature Limited 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-b3e5ec337c104d22cad5770fa9883037279861b358d1ab2cace4a9c0a4af88703</citedby><cites>FETCH-LOGICAL-c505t-b3e5ec337c104d22cad5770fa9883037279861b358d1ab2cace4a9c0a4af88703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31477839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Shaoshan</creatorcontrib><creatorcontrib>Ren, Xiaoli</creatorcontrib><creatorcontrib>Liang, Yunshi</creatorcontrib><creatorcontrib>Yan, Yongrong</creatorcontrib><creatorcontrib>Zhou, Yangshu</creatorcontrib><creatorcontrib>Hu, Jinlong</creatorcontrib><creatorcontrib>Wang, Zhizhi</creatorcontrib><creatorcontrib>Song, Fuyao</creatorcontrib><creatorcontrib>Wang, Feifei</creatorcontrib><creatorcontrib>Liao, Wangjun</creatorcontrib><creatorcontrib>Liao, Wenting</creatorcontrib><creatorcontrib>Ding, Yanqing</creatorcontrib><creatorcontrib>Liang, Li</creatorcontrib><title>KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>As an inhibitor of heat shock proteins (HSPs), KNK437 has been reported to play an anti-tumor role in several cancers. But its therapeutic effect and mechanisms in colorectal cancer (CRC) remain unclear. Here, KNK437 sharply inhibited the level of DnaJ heat shock protein family (Hsp40) member A1 (DNAJA1), followed by DNAJB1, but had little effect on the levels of HSP27, HSP105, HSP90, and HSP70 in CRC cells. DNAJA1 promoted CRC cell proliferation in vitro and tumor growth and metastasis in vivo. Mechanistically, DNAJA1 was activated by E2F transcription factor 1 (E2F1) and then promoted cell cycle by stabilizing cell division cycle protein 45 (CDC45), which could be reversed by KNK437. DNAJA1 was significantly upregulated in CRC tissues and positively correlated with serosa invasion, lymph node metastasis. High level of DNAJA1 predicted poor prognosis for CRC patients. Its expression was highly linked with E2F1 and CDC45 in CRC tissues. More importantly, KNK437 significantly suppressed the growth of DNAJA1 expressing tumor in vivo. The combined treatment of KNK437 with 5-FU/L-OHP chemotherapy reduced liver metastasis of CRC. These data reveal a novel mechanism of KNK437 in anti-tumor therapy of CRC and provides a newly therapeutic strategy with potential translation to the CRC patients.</description><subject>13/1</subject><subject>13/109</subject><subject>13/2</subject><subject>13/51</subject><subject>38/44</subject><subject>38/77</subject><subject>38/89</subject><subject>631/67/1059/602</subject><subject>631/67/1504/1885</subject><subject>64/60</subject><subject>82/80</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Benzhydryl Compounds - pharmacology</subject><subject>Cdc45 protein</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell division</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Chemotherapy</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Cycle protein</subject><subject>E2F1 protein</subject><subject>E2F1 Transcription Factor - genetics</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Growth</subject><subject>Health aspects</subject><subject>Heat shock proteins</subject><subject>Heat-Shock Proteins - antagonists &amp; inhibitors</subject><subject>Hsp27 protein</subject><subject>HSP40 Heat-Shock Proteins - genetics</subject><subject>Hsp40 protein</subject><subject>Hsp70 protein</subject><subject>Hsp90 protein</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Lymph nodes</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Medicine, Experimental</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Neoplasm Metastasis</subject><subject>Oncology</subject><subject>Proteins</subject><subject>Pyrrolidinones - pharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kV1vVCEQhonR2LX6A7wxJF6fdvg6wOVm62ebeqPXZJbDOaXZc6jA-vHvZbPVxkQDCRPmeYcZXkJeMjhjIMx5kUwY0wGzHVjdgkdkxaTuO6WsfExWYBV0lgt-Qp6VcgsA2gJ_Sk5Eo7QRdkXc5fWlFJrmUGqOvhZabwKdcvpebyguA51DxdJ2LDSN1KddysFX3FGPiw-ZfotIK-Yp1LhM9OJ6_XHNzjcXG6ko_ojlOXky4q6EF_fnKfny9s3nzfvu6tO7D5v1VecVqNptRVDBC6E9Azlw7nFQWsOI1hgBQnNtTc-2QpmB4balfZBoPaDE0RgN4pS8Pta9y-nrvg3jbtM-L-1Jx4Xk7Zs4Yw_UhLvg4jKmmtHPsXi37hmYXlroG3X2D6qtIczRpyWMsd3_JWBHgc-plBxGd5fjjPmnY-AOTrmjU6455Q5OuUPDr-4b3m_nMPxR_LamAfwIlJZappAfJvp_1V_v9pql</recordid><startdate>20200109</startdate><enddate>20200109</enddate><creator>Yang, Shaoshan</creator><creator>Ren, Xiaoli</creator><creator>Liang, Yunshi</creator><creator>Yan, Yongrong</creator><creator>Zhou, Yangshu</creator><creator>Hu, Jinlong</creator><creator>Wang, Zhizhi</creator><creator>Song, Fuyao</creator><creator>Wang, Feifei</creator><creator>Liao, Wangjun</creator><creator>Liao, Wenting</creator><creator>Ding, Yanqing</creator><creator>Liang, Li</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20200109</creationdate><title>KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis</title><author>Yang, Shaoshan ; Ren, Xiaoli ; Liang, Yunshi ; Yan, Yongrong ; Zhou, Yangshu ; Hu, Jinlong ; Wang, Zhizhi ; Song, Fuyao ; Wang, Feifei ; Liao, Wangjun ; Liao, Wenting ; Ding, Yanqing ; Liang, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-b3e5ec337c104d22cad5770fa9883037279861b358d1ab2cace4a9c0a4af88703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>13/1</topic><topic>13/109</topic><topic>13/2</topic><topic>13/51</topic><topic>38/44</topic><topic>38/77</topic><topic>38/89</topic><topic>631/67/1059/602</topic><topic>631/67/1504/1885</topic><topic>64/60</topic><topic>82/80</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Benzhydryl Compounds - pharmacology</topic><topic>Cdc45 protein</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell division</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Chemotherapy</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Cycle protein</topic><topic>E2F1 protein</topic><topic>E2F1 Transcription Factor - genetics</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Growth</topic><topic>Health aspects</topic><topic>Heat shock proteins</topic><topic>Heat-Shock Proteins - antagonists &amp; inhibitors</topic><topic>Hsp27 protein</topic><topic>HSP40 Heat-Shock Proteins - genetics</topic><topic>Hsp40 protein</topic><topic>Hsp70 protein</topic><topic>Hsp90 protein</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Lymph nodes</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Medicine, Experimental</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Neoplasm Metastasis</topic><topic>Oncology</topic><topic>Proteins</topic><topic>Pyrrolidinones - pharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Shaoshan</creatorcontrib><creatorcontrib>Ren, Xiaoli</creatorcontrib><creatorcontrib>Liang, Yunshi</creatorcontrib><creatorcontrib>Yan, Yongrong</creatorcontrib><creatorcontrib>Zhou, Yangshu</creatorcontrib><creatorcontrib>Hu, Jinlong</creatorcontrib><creatorcontrib>Wang, Zhizhi</creatorcontrib><creatorcontrib>Song, Fuyao</creatorcontrib><creatorcontrib>Wang, Feifei</creatorcontrib><creatorcontrib>Liao, Wangjun</creatorcontrib><creatorcontrib>Liao, Wenting</creatorcontrib><creatorcontrib>Ding, Yanqing</creatorcontrib><creatorcontrib>Liang, Li</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Shaoshan</au><au>Ren, Xiaoli</au><au>Liang, Yunshi</au><au>Yan, Yongrong</au><au>Zhou, Yangshu</au><au>Hu, Jinlong</au><au>Wang, Zhizhi</au><au>Song, Fuyao</au><au>Wang, Feifei</au><au>Liao, Wangjun</au><au>Liao, Wenting</au><au>Ding, Yanqing</au><au>Liang, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2020-01-09</date><risdate>2020</risdate><volume>39</volume><issue>2</issue><spage>249</spage><epage>261</epage><pages>249-261</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><abstract>As an inhibitor of heat shock proteins (HSPs), KNK437 has been reported to play an anti-tumor role in several cancers. But its therapeutic effect and mechanisms in colorectal cancer (CRC) remain unclear. Here, KNK437 sharply inhibited the level of DnaJ heat shock protein family (Hsp40) member A1 (DNAJA1), followed by DNAJB1, but had little effect on the levels of HSP27, HSP105, HSP90, and HSP70 in CRC cells. DNAJA1 promoted CRC cell proliferation in vitro and tumor growth and metastasis in vivo. Mechanistically, DNAJA1 was activated by E2F transcription factor 1 (E2F1) and then promoted cell cycle by stabilizing cell division cycle protein 45 (CDC45), which could be reversed by KNK437. DNAJA1 was significantly upregulated in CRC tissues and positively correlated with serosa invasion, lymph node metastasis. High level of DNAJA1 predicted poor prognosis for CRC patients. Its expression was highly linked with E2F1 and CDC45 in CRC tissues. More importantly, KNK437 significantly suppressed the growth of DNAJA1 expressing tumor in vivo. The combined treatment of KNK437 with 5-FU/L-OHP chemotherapy reduced liver metastasis of CRC. These data reveal a novel mechanism of KNK437 in anti-tumor therapy of CRC and provides a newly therapeutic strategy with potential translation to the CRC patients.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31477839</pmid><doi>10.1038/s41388-019-0978-0</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2020-01, Vol.39 (2), p.249-261
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_journals_2342388211
source MEDLINE; Alma/SFX Local Collection
subjects 13/1
13/109
13/2
13/51
38/44
38/77
38/89
631/67/1059/602
631/67/1504/1885
64/60
82/80
Animals
Apoptosis
Benzhydryl Compounds - pharmacology
Cdc45 protein
Cell Biology
Cell cycle
Cell Cycle Proteins - genetics
Cell division
Cell proliferation
Cell Proliferation - drug effects
Chemotherapy
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - drug therapy
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Cycle protein
E2F1 protein
E2F1 Transcription Factor - genetics
Female
Gene Expression Regulation, Neoplastic - drug effects
Growth
Health aspects
Heat shock proteins
Heat-Shock Proteins - antagonists & inhibitors
Hsp27 protein
HSP40 Heat-Shock Proteins - genetics
Hsp40 protein
Hsp70 protein
Hsp90 protein
Human Genetics
Humans
Internal Medicine
Lymph nodes
Male
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Metastases
Metastasis
Mice
Neoplasm Metastasis
Oncology
Proteins
Pyrrolidinones - pharmacology
Signal Transduction - drug effects
Xenograft Model Antitumor Assays
title KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A27%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=KNK437%20restricts%20the%20growth%20and%20metastasis%20of%20colorectal%20cancer%20via%20targeting%20DNAJA1/CDC45%20axis&rft.jtitle=Oncogene&rft.au=Yang,%20Shaoshan&rft.date=2020-01-09&rft.volume=39&rft.issue=2&rft.spage=249&rft.epage=261&rft.pages=249-261&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/s41388-019-0978-0&rft_dat=%3Cgale_proqu%3EA610864906%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2342388211&rft_id=info:pmid/31477839&rft_galeid=A610864906&rfr_iscdi=true